1 terminated. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow pactimibe: new trials by email Literature Review of pactimibe trials Research Report on pactimibe
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Carotid Artery Disease. This Study is Also Known as CAPTIVATE. Pactimibe sulfate - Atherosclerosis, Heterozygous Familial Hypercholesterolemia | Phase 2 / Phase 3 | Terminated | Daiichi Sankyo | 796 | 2004-02-01 | 2012-01-18 |
Atherosclerosis (1)
Daiichi Sankyo (1)
Canada (1) · Israel (1) · Netherlands (1) · Norway (1) · South Africa (1) · Spain (1) · Sweden (1) · United Kingdom (1) · United States (1)